Compounds
US9487528B2 · kind B2 · utility
0Cited by
5References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2015 |
| Grant date | Nov 8, 2016 |
| Priority date | — |
| Expiry date | Jun 5, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I), described herein, exhibit human neutrophil elastase inhibitory properties, and are useful for the treatment of diseases and conditions in which HNE is implicated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.